Compass is still being developed and is effectively in beta. Some content and features may be incomplete, change, or not work as expected.

Content is anchored to trusted sources where available, but Compass has not yet been clinically reviewed. It provides general information rather than medical advice.

Feedback helps us identify gaps, errors, usability problems and opportunities to improve Compass over time.

How Compass is developedGive feedback

ALS Untangled says acupuncture needs better studies before testing in a phase II trial

Original source

AcupunctureALSUntangled · 11 May 2015 (opens in a new tab)

Acupuncture has been described as reasonably safe, with possible biological mechanisms and early evidence from preclinical studies and case reports in amyotrophic lateral sclerosis (ALS). ALS Untangled says these findings are not enough to support endorsement for a phase II trial. Independent studies with confirmed diagnoses, appropriate controls and validated ALS outcome measures are needed first.

Why this matters

This review does not establish that acupuncture improves ALS or changes treatment. People with ALS should understand that the evidence remains early and that acupuncture has not been endorsed as a treatment or for a phase II trial on the basis of the evidence discussed.

Limitations and context

This is an independent expert review, not a new clinical trial. The evidence described consists of preclinical studies and case reports, and the review calls for independent replication and more rigorous study designs before further endorsement.

Summarised by Compass 10 August 2026

This summary was generated by AI from the source listed above. It is not medical advice, so read the original source for anything that affects your care.

Relevant to you?